Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$147.50
-2.85%
Mkt Cap $15.71B
Analyst Ratings
Buy
32
Hold
5
Sell
0
Price Target (89 analysts)
$203.82
Range $165.00 – $230.00
Implied Upside
+38.2%
Consensus $203.82 vs current $147.50